Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis
Public ClinicalTrials.gov record NCT03334851. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 1, RANDOMIZED, MULTI-CENTER, DOUBLE-BLIND, SPONSOR OPEN, PLACEBO-CONTROLLED, SINGLE AND MULTIPLE DOSE-ESCALATION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF PF-06835375 IN SUBJECTS WITH SEROPOSITIVE SYSTEMIC LUPUS ERYTHEMATOSUS OR RHEUMATOID ARTHRITIS
Study identification
- NCT ID
- NCT03334851
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 74 participants
Conditions and interventions
Conditions
Interventions
- PF-06835375 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 16, 2017
- Primary completion
- Feb 14, 2022
- Completion
- Feb 14, 2022
- Last update posted
- Oct 29, 2023
2017 – 2022
United States locations
- U.S. sites
- 17
- U.S. states
- 7
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pinnacle Research Group, LLC | Anniston | Alabama | 36201 | — |
| Pinnacle Research Group, LLC | Anniston | Alabama | 36207 | — |
| Wallace Rheumatic Studies Center | Beverly Hills | California | 90211 | — |
| Prive aftercare | Los Angeles | California | 90048 | — |
| Clinical Research of West Florida, Inc. | Clearwater | Florida | 33765 | — |
| Private Practice of Robert W. Levin, MD | Clearwater | Florida | 33765 | — |
| Avail Clinical Research | DeLand | Florida | 32720 | — |
| Omega Research Maitland, LLC | Orlando | Florida | 32808 | — |
| Larkin Hospital | South Miami | Florida | 33143 | — |
| Qps Mra, Llc | South Miami | Florida | 33143 | — |
| Qps-Mra, Llc | South Miami | Florida | 33143 | — |
| PAREXEL International - EPCU Baltimore | Baltimore | Maryland | 21225 | — |
| Rheumatology Express | Catonsville | Maryland | 21228 | — |
| Carolina Phase 1 Research, LLC | Raleigh | North Carolina | 27612 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Metroplex Clinical Research Center | Dallas | Texas | 75231 | — |
| MPP Infusion Centers | Dallas | Texas | 75231 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03334851, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 29, 2023 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03334851 live on ClinicalTrials.gov.